GloGlo

GloGlo is a San Francisco biotech company focused on autoimmune diseases, beginning with type 1 diabetes. It combines AI research agents with experimental biology to study how to restore insulin production and stop the immune attack on beta cells, covering stem-cell-derived beta cells, T-cell-recognized molecules, and pancreatic tissue in autoimmunity. The company also sells consumer products for people living with diabetes, with proceeds supporting its research.

Research areas include cell replacement, immune tolerance, and beta-cell-selective treatments, using computational models alongside experimental data. Its consumer products include GloGlo Gummies, dextrose gummies for raising low blood sugar, available through Amazon, TikTok Shop, and retailers including Fresh Thyme, and GloGlo AI for iPhone and Android, which tracks food, estimates carbs from a photo, and provides personalized AI coaching. The company was founded by Marie Schneegans and Michael Fester and is backed by Y Combinator.